ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 70 filers reported holding ACELRX PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 1.87 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $15,000 | -6.2% | 14,520 | +26.1% | 0.00% | – |
| Q2 2021 | $16,000 | -88.7% | 11,513 | -86.3% | 0.00% | – |
| Q1 2021 | $142,000 | +343.8% | 83,935 | +224.9% | 0.00% | – |
| Q4 2020 | $32,000 | -38.5% | 25,835 | -29.3% | 0.00% | – |
| Q3 2020 | $52,000 | -42.2% | 36,523 | -51.5% | 0.00% | – |
| Q2 2020 | $90,000 | +200.0% | 75,340 | +190.0% | 0.00% | – |
| Q1 2020 | $30,000 | -81.9% | 25,981 | -67.1% | 0.00% | – |
| Q4 2019 | $166,000 | +88.6% | 78,868 | +94.7% | 0.00% | – |
| Q3 2019 | $88,000 | -31.2% | 40,498 | -20.0% | 0.00% | – |
| Q2 2019 | $128,000 | -78.9% | 50,640 | -70.9% | 0.00% | – |
| Q1 2019 | $606,000 | -24.7% | 174,175 | -50.1% | 0.00% | -100.0% |
| Q4 2018 | $805,000 | +7218.2% | 348,837 | +10159.9% | 0.00% | – |
| Q2 2018 | $11,000 | +450.0% | 3,400 | +276.1% | 0.00% | – |
| Q4 2017 | $2,000 | -99.2% | 904 | -98.4% | 0.00% | – |
| Q3 2017 | $260,000 | -9.4% | 56,473 | -57.7% | 0.00% | – |
| Q2 2017 | $287,000 | +1588.2% | 133,590 | +2292.8% | 0.00% | – |
| Q1 2017 | $17,000 | +750.0% | 5,583 | +777.8% | 0.00% | – |
| Q4 2016 | $2,000 | +100.0% | 636 | +185.2% | 0.00% | – |
| Q3 2016 | $1,000 | – | 223 | +7333.3% | 0.00% | – |
| Q4 2015 | $0 | -100.0% | 3 | -100.0% | 0.00% | – |
| Q3 2015 | $46,000 | +228.6% | 15,372 | +327.0% | 0.00% | – |
| Q2 2015 | $14,000 | 0.0% | 3,600 | -24.9% | 0.00% | – |
| Q1 2015 | $14,000 | -53.3% | 4,792 | -4.4% | 0.00% | – |
| Q4 2014 | $30,000 | -11.8% | 5,012 | -25.2% | 0.00% | – |
| Q3 2014 | $34,000 | -68.2% | 6,702 | -38.1% | 0.00% | – |
| Q2 2014 | $107,000 | -6.1% | 10,828 | +15.2% | 0.00% | – |
| Q1 2014 | $114,000 | +81.0% | 9,398 | +62.6% | 0.00% | – |
| Q4 2013 | $63,000 | +600.0% | 5,780 | +562.1% | 0.00% | – |
| Q3 2013 | $9,000 | -10.0% | 873 | -20.4% | 0.00% | – |
| Q2 2013 | $10,000 | – | 1,097 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 6,574,060 | $27,874,000 | 1.68% |
| SENZAR ASSET MANAGEMENT, LLC | 798,381 | $3,385,000 | 0.58% |
| Cormorant Asset Management, LP | 850,000 | $3,604,000 | 0.48% |
| Palo Alto Investors LP | 2,135,739 | $9,056,000 | 0.40% |
| Opus Point Partners Management, LLC | 99,959 | $424,000 | 0.34% |
| Granahan Investment Management | 1,582,237 | $6,709,000 | 0.19% |
| Joel Isaacson & Co., LLC | 70,660 | $300,000 | 0.08% |
| MARINER INVESTMENT GROUP LLC | 59,700 | $253,000 | 0.06% |
| MYCIO WEALTH PARTNERS, LLC | 75,000 | $318,000 | 0.06% |
| Cornerstone Capital, Inc. | 59,200 | $251,000 | 0.06% |